Control-IQ Technology
Software Version 7.8What's New
This software update supports Dexcom G7 continuous glucose monitoring (CGM)* integration with the t:slim X2 insulin pump. Dexcom G6 sensors will still be compatible with your pump after updating. Here are some additional new features:
Exercise Timer
You can now set a timer between 30 minutes and 8 hours for a duration when using the Exercise Activity.
Activity Transition
You can now start an activity on your t:slim X2 insulin pump without having to stop another activity, if it was active.
Sensor Alerts
The Sensor Expiring Soon alert will show at 24 hours, 2 hours, and 30 minutes remaining before your session ends.†
This update requires completion of online training, which must be initiated through your account in order to update your pump software.
Confirm your eligibility and learn about requirements.‡
* CGM sold separately.
† The Dexcom G7 CGM sensor is indicated to be worn for up to 10 days, plus an additional 12-hour grace period. During the 12-hour grace period, the pump will continue to receive sensor glucose readings and allow use of predictive technologies.
‡ Additional feature updates may not be currently available for the t:slim X2 insulin pump with Control-IQ technology and are subject to Health Canada clearance. Additional training may be required to access certain future software updates. Software updates are only available to customers who are in warranty at the time they update their pump. Charges may apply. Future updates for all or some Tandem products may not be developed and may not be offered everywhere. Tandem may discontinue select software and features over time at its discretion.
Important Safety Information
This product may not be right for you. Always read and follow the label.
The t:slim X2 insulin pump with Control-IQ technology (the System) consists of the t:slim X2 insulin pump, which contains Control-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the System. When used with a compatible CGM, the System can be used to automatically increase, decrease, and suspend delivery of basal insulin based on CGM sensor readings and predicted glucose values. The System can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The pump and the System are indicated for use in individuals 6 years of age and greater. The pump and the System are intended for single user use. The pump and the System are indicated for use with NovoRapid, Admelog, Trurapi, or Humalog U-100 insulin. The System is intended for the management of Type 1 diabetes.
Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 25 kilograms.
The System is not indicated for use in pregnant women, people on dialysis, or critically ill users. Do not use the System if using hydroxyurea.
Users of the pump and the System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. If your CGM readings do not match your symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. The t:slim X2 pump must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
The Tandem Source platform is intended for use by individuals with diabetes mellitus who use Tandem Diabetes Care insulin pumps, their caregivers, and their healthcare providers in home and clinical settings. The Tandem Source platform supports diabetes management through the display and analysis of information uploaded from Tandem insulin pumps.